C3 and lobular neoplasia: Testing for anti-dsDNA, anti-C1q autoantibodies, and complement levels (C3 and C4) should be considered in patients with suspected LN [7]. Levels of anti-ds DNA Ab reflect disease presence and activity in patients with LN [10].